Healthcare Sales in 2026: Engaging Hard-to-Reach Decision-Makers & When to Outsource for B2B Success

Introduction

Healthcare sales in 2026 isn’t for the faint of heart. If your team is struggling to get a response from busy hospital executives or physicians, you’re not alone: healthcare decision-makers are harder to reach than ever, buying cycles are longer, and a single deal can involve nearly a dozen stakeholders. Having run outbound for 2,000+ B2B brands across 50+ verticals over 16+ years — and ranked #1 in Lead Generation on Clutch — we’ve watched what works in medtech and health-tech selling shift channel by channel, and this guide lays out what’s working now.

One clarification up front, because the term splits two ways: “healthcare sales” can mean the career (becoming a medical or device sales rep) or the B2B motion of selling products and services into hospitals, clinics, and health systems. This guide is about the second. Below, we cover new tactics for engaging hard-to-reach healthcare buyers and when it makes sense to lean on healthcare lead generation support and outsourced SDRs to boost B2B sales success.

Healthcare Sales at a Glance

1. Healthcare sales is the B2B process of selling medical devices, health software, and services into hospitals, clinics, and health systems — long cycles, strict compliance, and committee buying define it.
2. A typical healthcare technology deal takes about 12 months and involves roughly nine decision-makers (Salesmotion), so multi-stakeholder messaging beats a single-champion pitch.
3. Most of the buying journey happens before you’re contacted — B2B buyers are about 70% through their decision before they speak to a rep (DemandGen Report) — so trusted content and presence have to do early work.
4. Omnichannel persistence wins the meeting: it takes around eight touches across email, phone, and LinkedIn to convert (Rain Group).
5. Outsourcing healthcare sales pays off when prospecting is starving your pipeline or you need to enter a market fast — a matched partner can ramp roughly 3x faster than an in-house build.

The 2026 Shift: What’s Different This Year

• The digital-first buying shift Gartner forecast — 80% of B2B interactions moving to digital channels by 2025 — has now largely played out; in Gartner’s late-2025 research, about 61% of B2B buyers said they prefer a rep-free buying experience, so generic outreach gets filtered faster than ever.
• AI-assisted prospecting moved from edge to expectation: intent data and AI SDR tooling now decide who gets touched and when, concentrating healthcare outreach on accounts already in-market.
• Hospital procurement keeps adding scrutiny — recent vendor research finds the majority of U.S. hospitals now involve six or more stakeholders in major purchases — pushing sellers toward layered, role-specific messaging.
• Outsourced SDR models shifted from staff-augmentation to dedicated, single-team ownership of a healthcare market end-to-end, reflecting how much domain context a healthcare campaign now requires.

Key Terms, Defined

• Healthcare sales is the B2B sale of medical devices, health software, diagnostics, or services to provider organizations like hospitals, clinics, and health systems.
• Value Analysis Committee (VAC) is the cross-functional hospital group that weighs a purchase on cost, clinical outcome, and risk before it can be approved.
• IDN (Integrated Delivery Network) is a network of affiliated hospitals and care sites that buy as one system, so a single win can scale across many facilities.
• Omnichannel outreach is a coordinated, sequenced cadence across email, phone, and LinkedIn where each channel reinforces the others — distinct from parallel, uncoordinated “multichannel” blasting.
• SDR (Sales Development Representative) is the rep who researches accounts and runs early outreach to book qualified meetings for closers.
• Fractional SDR team is a dedicated outsourced team that owns a market end-to-end, framed as unbroken ownership rather than part-time help.
• ICP (Ideal Customer Profile) is the precise definition of the healthcare accounts and personas worth pursuing, which keeps outreach focused and qualification honest.

How and why: this guide draws on current public research and Martal’s experience running B2B outbound and pipeline generation for healthcare clients. We put it together to help medtech, health-SaaS, and medical-services teams reach the right buyers and decide when outsourcing is the faster path.

The Modern Healthcare Sales Landscape: Why Decision-Makers Are Harder to Reach

Healthcare buyers are hard to reach because the purchase is complex, consensus-driven, and slow by design. A typical B2B healthcare purchase involves roughly nine decision-makers or influencers on the buying committee, and the average healthcare technology buying cycle runs about 12 months (Salesmotion) — far longer than many other B2B industries. During that year you may need buy-in from a hospital administrator, a chief medical officer, an IT director, and a finance manager, each with different priorities.

Buyers also do more independent research than ever. B2B buyers are roughly 70% through their decision-making process before they ever contact a sales rep (DemandGen Report). In healthcare, decision-makers read industry reports, compare solutions online, and consult peers long before they’ll schedule a meeting, so your sales team often isn’t invited until the buyer has formed a strong opinion. The digital-first shift Gartner forecast for 2025 has now arrived in full: about 61% of B2B buyers prefer a rep-free buying experience (Gartner), which means generic outreach is screened out fast.

Finally, healthcare professionals are busy and guarded. Packed schedules, gatekeepers, and privacy regulation all restrict direct outreach, and decision-makers have grown adept at tuning out generic pitches. Breaking through takes a smarter, more targeted approach — the tactics below are built for exactly that.

Users in Reddit and community discussions often ask how to sell into hospitals without getting stuck in an endless evaluation loop. The consensus from sellers who’ve done it is consistent: hospital sales is its own discipline, and the most common failure is treating it like any other B2B deal. Sellers who map their cadence to the hospital’s buying rhythm — clinical need, committee review, pilot, procurement — move forward with far less friction than those who push a standard timeline onto a risk-averse buyer.

Engaging Hard-to-Reach Healthcare Decision-Makers: New B2B Tactics for 2026

Opening doors that seem firmly shut comes down to meeting healthcare buyers on their terms — strategic targeting, real personalization, and persistence across channels. Here are the tactics that consistently earn the meeting.

1. Account-Based Marketing and Hyper-Personalization

In healthcare sales, a laser-focused Account-Based Marketing (ABM) strategy is close to a necessity, because personalization pays off: around 95% of B2B buyers say personalized outreach influences their purchasing decisions (HubSpot). Rather than casting a wide net, an ABM agency can help you identify high-value target accounts — a list of top hospital systems or large clinics — and tailor everything to them.

Start by researching each target account’s structure and pain points. Who are the key players — a chief medical officer, head of procurement, IT lead? Effective healthcare sales and marketing alignment matters here, because the insights your reps gather should feed campaign messaging so every stakeholder hears something built for their role. If you’re presenting a hospital communication app, connect it to a pressing need like reducing response times or breaking down silos. Craft bespoke content per persona: the CFO gets an ROI analysis, the clinician lead sees evidence of improved care, and the IT director receives integration and data-security detail. That one-to-one approach signals you understand their world, immediately setting you apart from generic vendors.

Personalization extends to small details too — use the prospect’s name and organization, reference recent news about their hospital, or cite a public initiative. At scale, intent-data tools and AI prospecting platforms now flag when a healthcare organization is actively researching a solution like yours, so you can time outreach precisely. In 2026 there’s no excuse for a one-size-fits-all sales pitch — hyper-personalization is the price of entry for tough accounts.

2. Omnichannel Outreach with Persistent Multi-Touch Sequences

Hard-to-reach prospects rarely respond to a single email, but they often respond by the fifth or eighth touch when you vary the approach. It takes about eight touchpoints on average to generate a B2B conversion (Rain Group), which is why an omnichannel cadence — email, phone, LinkedIn, even direct mail — beats any one channel. Each touch reinforces the others, giving you multiple shots at connecting and building familiarity.

A sequence might open with a personalized email sharing a relevant insight (“Dr. Smith, I thought you’d want this case study on reducing ER wait times”). A few days later, connect on LinkedIn and engage with their posts. Next, a courteous phone attempt referencing the email. Then another email follow-up highlighting a different value prop, and so on. By the time you’ve touched them five to eight times, you’re no longer a stranger — you’re the persistent, helpful contact who clearly knows their needs.

Use each channel for its strength. Cold calling is far from dead — a live conversation or a personable voicemail conveys credibility and emotion an email can’t. LinkedIn warms a lead with lighter touches that build name recognition. Email carries detail and persistent nudges prospects can read on their own time. Plan a thoughtful cadence (Email Day 1, LinkedIn Day 3, Call Day 5, follow-up Email Day 7) and make each touch say something a little different. Professional persistence signals confidence in the value you’re offering — as long as every touch adds value and isn’t just “checking in.”

3. Thought Leadership Content that Builds Trust

Engaging healthcare buyers is also about convincing them, and given how research-driven they are, thought leadership is one of your most powerful tools. About 90% of decision-makers in healthcare tech report struggling to find high-quality, trusted content to inform their decisions (Spot On Agency) — they’re actively seeking credible information, so if you become the source, you become the vendor they want to talk to.

Position your company and sales execs as experts on the problems your solution solves: whitepapers on emerging trends, informative blogs and LinkedIn articles, webinars, contributed pieces in healthcare publications. The focus is value, not pitching. A medical software provider might publish a guide to new healthcare data regulations; a device firm might summarize recent clinical studies validating its approach. When a hospital administrator or physician hits that content during self-guided research, your credibility jumps.

Content also supports the sales cycle directly. It gives SDRs and reps useful “leave-behinds” for follow-ups, keeps your brand on a prospect’s radar during the long nurture phase, and arms your internal champion with evidence to persuade the buying committee. Since most buyers now spend very little time meeting vendors in person, thought leadership “sells” for you when you’re not in the room — establishing trust in a non-salesy way until a receptive response to your outreach becomes natural.

4. Consultative, Value-Driven Selling (Show ROI and Outcomes)

When you do get a healthcare decision-maker’s time, win it by acting less like a salesperson and more like an advisor. It matters because B2B buyers are about 70% through their decision before speaking to a rep (DemandGen Report) — by the time you’re in the room, generic pitching falls flat, but genuine problem-solving lands.

Start with good questions. What internal challenge prompted their interest? What outcome are they after — reduced readmissions, better care coordination, lower operating costs? Leading with questions shows empathy and gives you the intel to tailor your pitch. Then frame your solution entirely around their priorities: “You mentioned speeding patient intake — our automated intake forms could shorten that by 30%, freeing staff to focus on care.” Tie features to benefits, and benefits to outcomes that resonate in healthcare: better patient care, compliance, cost savings, revenue.

Back every claim with data, because this is a skeptical sector. Bring ROI calculators, case studies, and hard evidence — “Hospital X cut ER wait times 25% and saved $500K annually.” Many hospitals run Value Analysis Committees that demand financial justification, so arm your champion with the numbers to win them over. Stories help too: healthcare runs on impact, and a narrative about lives improved sticks where a spec sheet won’t. And don’t dodge compliance, privacy, and integration questions — addressing HIPAA and IT integration proactively shows you get their world. The more the conversation is about the buyer’s success and less about your product, the more trust you earn.

5. Leveraging Peer Influence and Referrals

Healthcare is a tight-knit community, and peer influence opens doors traditional outreach can’t — roughly 84% of B2B decision-makers begin the buying process with a referral (DemandSage). Doctors talk to doctors, hospital CEOs talk to peers at conferences, and everyone watches what leading institutions do.

If you have satisfied healthcare clients, ask for referrals and introductions. A warm note from a CXO at a hospital you’ve served can massively boost credibility with a new target. Public testimonials and case studies featuring recognizable healthcare brands carry real weight, because risk-averse decision-makers take comfort in “Hospital ABC already implemented this.” You can also create peer interaction directly: roundtable webinars or local dinners where a happy customer shares their story let validation happen in real time. Even citing respected institutions in conversation (“a similar approach was recently adopted at a leading academic medical center”) signals your solution is becoming a standard.

Another tactic: identify key opinion leaders (KOLs) — a renowned surgeon or health-IT expert — and build genuine relationships. Their endorsement acts as a trust bridge to your buyers, provided it’s authentic; healthcare folks spot a purely paid plug instantly. Treat peer influence as a force multiplier: when a prospect has already heard about you from colleagues, that hard-to-reach buyer gets a lot easier to engage.

6. Embracing Digital Engagement and Social Selling

As healthcare goes more digital (telemedicine, virtual conferences, online professional networks, and prescription services like liraglutide online), your sales engagement has to follow. Social selling — especially via LinkedIn — builds relationships over time, and social content influences about 25% of B2B deals (HubSpot), largely by nurturing trust and familiarity. Many hospital executives and health-tech professionals stay active on LinkedIn, so connecting and interacting keeps you on their radar in a low-pressure way.

Make sure your profile and company page showcase healthcare expertise — relevant articles, commentary on industry news, customer success stories. Join healthcare groups and forums where prospects gather and contribute thoughtfully without pitching. Over time this positions you as a knowledgeable peer. Share a short “3 Takeaways from the Latest CMS Policy Change” post or congratulate a hospital leader on an award; small interactions add up to visibility, so when a need arises, you’re who they think of.

Don’t overlook interactive formats. A live webinar or AMA on a hot healthcare topic can draw prospects you then follow up with (“Thanks for joining our session on AI in Healthcare — I noticed you were interested in X”). Virtual lunch-and-learns and on-demand demos cater to busy schedules, letting decision-makers engage on their terms. Keep a professional but human tone; a little personality makes your team relatable, and prospects who feel like they know you are far likelier to respond when you reach out directly.

Healthcare Sales and Marketing Alignment: A Foundation for Consistent Pipeline Growth

One of the most under-leveraged drivers of healthcare sales performance is how tightly sales and marketing operate as a single unit. From the outbound execution side, this isn’t theoretical: when cycles stretch to 12 months and decisions involve nine or more stakeholders, misalignment shows up as lower reply rates, longer qualification, and prospects who receive contradictory messaging across channels.

When healthcare sales and marketing teams share a unified ICP, consistent messaging, and a common definition of pipeline quality, every outreach effort compounds on the last. We see it most clearly in weekly campaign reviews with healthcare clients: the campaigns that perform best are the ones where the value narrative our SDRs use in cold outreach mirrors what marketing publishes on LinkedIn, in case studies, and through webinars. A risk-averse hospital buyer who hears one coherent message across every touchpoint trusts it faster than one forced to reconcile two stories.

The most practical place to start is the qualification line — a shared definition of a real opportunity. Without it, marketing passes contacts sales won’t act on, and sales chases accounts marketing already flagged as low-fit. The teams that close the most healthcare deals run a monthly review where both functions analyze the same pipeline data: which campaigns produced the strongest conversations, which personas qualified fastest, and where deals stalled. In a sector where one poorly timed outreach to a busy hospital executive can stall a relationship for months, that feedback loop isn’t optional.

B2B Medical Device Sales: Tactics to Navigate Complex Hospital Deals

B2B medical device sales exemplifies the challenges of healthcare sales, often on an even tougher setting. Device reps once thrived on in-person relationships — reps in hospital halls, scrubbing into operating rooms — but by 2026 access has tightened and new tactics are required. Here are lead generation strategies that work in medtech.

• Educate and influence the entire care team. Selling a surgical robot or diagnostic machine means winning over surgeons and the administration holding the purse strings. Identify a physician champion early, arm them with clinical evidence and trial opportunities, then equip them with economic data for the CFO or Value Analysis Committee. A one-page “economic value” summary quantifying reduced complications or shorter length of stay helps your champion answer the VAC’s questions. Sell the clinical team on outcomes and the admin team on ROI — you need both.
• Leverage clinical data and trials as proof. Device stakeholders are evidence-driven, so bring strong clinical studies, FDA clearances, and real-world data front and center. Where possible, have a respected physician co-author a case study or present; peer-reviewed proof and a fellow clinician’s endorsement sway even skeptical committees. Be ready to discuss FDA approval status in detail.
• Adapt to hybrid and virtual engagement. You won’t always get unfettered OR access, so be ready with virtual demos, pre-recorded device walkthroughs, and even VR/AR “test drives.” In-person demos still matter for complex devices, but a virtual backup keeps the process moving and signals a modern, flexible support model, including remote sales support post-sale.
• Navigate procurement and compliance early. Devices carry unique contracting, warranty, and regulatory compliance considerations. Proactively walk through installation, staff training, credentialing, and certifications so deal-killing objections don’t surface late. Hospitals reward vendors who make procurement smooth.
• Be present where your customers learn. Many purchasing ideas spark at conferences, trade shows, and in journals. Keep a presence — physical or sponsored — at major specialty events, and encourage happy physician customers to speak on panels. When a prospect sees your device praised by peers in a professional forum, trust builds fast.

In short, B2B medical device sales balances high-tech selling with old-fashioned relationship building. You’re dealing with life-and-death products, so credibility is everything. Educate stakeholders, prove value with data, and be a reliable partner through evaluation, and you can win these complex deals — the payoff is a multi-year, high-value contract and a deep partnership.

B2B Medical Sales Beyond Devices: Selling Healthcare Software and Services

Outside devices, the broader world of B2B medical sales — from healthcare SaaS to outbound consulting services to medical supplies — carries its own considerations. Many tactics apply universally (personalization, multi-touch, thought leadership), while healthcare software development increasingly shapes the digital tools providers need, from patient portals to analytics platforms, and virtual-care expansion makes telemedicine app development services more relevant. A few additional pointers for selling on the software or service side:

• Align with healthcare priorities (and buzzwords). Health organizations in 2026 are focused on patient experience, interoperability, population health, telehealth, data security, and value-based care. Map your solution explicitly to those initiatives. An AI Scribe for clinicians should show how it cuts administrative burden and frees providers for patient care. Speak the buyer’s language: if they announced a “Digital Transformation” or “AI in healthcare” initiative, frame your solution as accelerating exactly that.
• Emphasize integration and IT friendliness. A hospital weighing new software (an EMR add-on, a lead generation tool) cares deeply about how it plays with existing systems. Have answers ready on APIs, data formats, security, and implementation support, and offer references from IT leaders who praise your ease of integration. Partnering with an Epic EMR integration company strengthens the pitch by demonstrating expertise with one of the most widely used systems.
• Navigate regulatory and privacy requirements. Whether it’s HIPAA, HITRUST, or other regulations, compliance is non-negotiable. Build it into the pitch: a patient communications platform should highlight HIPAA-compliant encryption and audit trails. A one-pager listing your healthcare compliance credentials can accelerate approval from legal and compliance teams.
• Offer pilot programs or trials. Healthcare organizations like to “try before they buy.” A 60-day trial in one department or a small-scale project lowers the barrier; over-deliver on support, measure outcomes, and you’ll have ROI data from their own environment to justify the full rollout. Many successful health-SaaS companies use this land-and-expand path.
• Highlight post-sale support and partnership. Buyers want to know you’ll be by their side after signing. Emphasize onboarding, training, and ongoing support — a dedicated customer success contact with hospital-workflow experience, clear response times, and a change-management plan. This calms the common fear of “we buy it and our staff never fully use it.”

In short, selling B2B medical solutions means being deeply attuned to healthcare operations. Prove your product drives the outcomes organizations care about and that you’ll make those outcomes easy to reach — through integration, compliance, and support — and you’ll stand out. Remember your competition isn’t only other vendors; it’s inertia and in-house builds. Address every concern and smooth the path to value, and you tip the scales toward moving forward.

Outsourcing Healthcare Sales in 2026: When to Leverage Lead Generation Partners

Even with sharp tactics, breaking into healthcare accounts is a slow grind, which is why many medtech and health-SaaS companies ask whether to outsource parts of their sales process to accelerate results. The honest answer: only about 35% of a sales rep’s time is spent actively selling — the rest goes to admin, research, and prospecting (Close) — so the question is really about where an external team can buy back selling time. In 2026, healthcare sales outsourcing is common in B2B, and an outsourced lead generation or SDR team can act as a force multiplier for your in-house salesforce.

Users in Reddit and community discussions often ask whether to outsource medical sales or hire a distributor without losing control of the relationship. The practical consensus: outsourcing rarely has to be all-or-nothing. Hybrid models — keeping closing in-house while a partner runs top-of-funnel — let you buy speed and reach while your team owns the customer relationship.

Signs It’s Time to Outsource Your Healthcare Lead Generation

You should consider outsourcing when prospecting consistency, speed, or cost has become the constraint on pipeline. Here are the clearest signals:

• Limited bandwidth is choking your pipeline. If your AEs are expected to prospect and close, prospecting falls to the back burner and you get a feast-or-famine lead flow. An outsourced team generates healthcare sales leads continuously, so prospecting doesn’t stop the moment reps get busy closing.
• Reps spend more time searching than selling. With only about 35% of rep time spent selling, the hours lost to combing LinkedIn for emails and updating CRM fields are expensive. Outsourcing the labor-intensive hunting frees your closers for demos and negotiations — and they’re usually happier for it.
• You need to scale fast or explore new markets. Launching a product for hospitals, or entering the US healthcare market from abroad, demands meetings now. A matched partner can ramp roughly 3x faster than hiring and training in-house SDRs, since they arrive with trained people and proven processes. For time-sensitive pushes, outsourcing buys speed.
• High in-house costs or missing tools. The fully loaded cost of an in-house SDR and BDR team — salary, benefits, management, tooling, turnover — adds up, and healthcare reps command premium pay. Outsourcing can be 43–65% more cost-effective than in-house when all factors are counted (Movate), and partners bring premium databases, intent data, and compliant outreach you might not afford alone.
• Struggling to penetrate key accounts. Lead-gen partners often specialize in cracking “hard to reach” accounts through persistent multi-channel effort. They won’t replace your relationship managers, but they can secure that first conversation — and outsourced efforts have been found to produce about 43% more sales opportunities than internal efforts alone (Movate).

Outsourcing isn’t all-or-nothing. Hybrid models are common: retain account management and closing internally while a partner handles appointment setting or outbound prospecting. The point is to recognize where an external expert amplifies results and relieves pressure on your team.

The Benefits of Outsourced Lead Generation for Healthcare Sales

A reputable lead generation partner delivers several concrete benefits in a field as complex as healthcare. Here’s what you stand to gain:

• Faster time to pipeline. An outsourced team hits the ground running. At Martal, we’ve onboarded new healthcare lead generation campaigns in weeks because the team already knows medtech outreach — no six-month learning curve. In one engagement with a healthcare AI supply-chain company, our team delivered 128 leads, 76 MQLs, 31 SQLs, and 21 booked meetings over a nine-month campaign; the client’s CEO described it as bringing in “a steady stream of opportunities.” Read the full healthcare and medical use case.
• Access to sales expertise and proven playbooks. Outsourcing means hiring a crew that lives sales development — people who know which subject lines get busy hospital admins to open, how to navigate phone trees, and how to angle value props per healthcare persona. They arrive with tested cadences and sequences, no trial-and-error on your dime. Our SDR healthcare team, for instance, brings years of know-how engaging hospital IT directors, medical practice owners, and biotech leaders.
• Omnichannel, multi-touch outreach at scale. An outsourced team is built to execute the eight-plus touches across email, phone, and LinkedIn that healthcare prospects require (Rain Group), persisting through a structured cadence where an internal rep might send two emails and give up. The result is higher contact and engagement rates.
• Advanced tools and data insights. Good partners bring premium contact databases, automation, dialers, and — increasingly — AI and intent data to prioritize accounts that are “in-market.” Replicating that stack internally is costly and complex; outsourcing effectively rents the tools and the experts to run them.
• Greater volume and quality of leads. A dedicated team simply reaches more prospects, but it’s not only volume — partners work from a defined ICP and qualification criteria so you receive relevant, sales-ready opportunities. Notably, about 85% of B2B decision-makers in one survey said external lead-gen teams had a positive impact on pipeline performance (Movate).
• Cost efficiency and flexibility. Effective cost-per-lead often drops, and engagements scale up or down faster than hiring or downsizing staff. Tiered packages let healthcare startups start small and scale as results come, and a partner can pivot messaging or segments quickly when something isn’t working.
• Focus on core strengths. By offloading the grunt work of prospecting, your AEs pour time into demos, relationships, and closing — which is exactly why about 65% of companies cite “enabling focus on core business” as a top benefit of outsourcing (Exploding Topics).

Choosing a Healthcare Sales Lead Gen Partner (and Making It Work)

Not all providers are equal, and healthcare sales is nuanced, so choose a partner with relevant experience and a compatible approach. A few tips:

• Find a partner with healthcare pedigree. Do they have case studies or clients in medical or health-SaaS sectors like yours? Are their reps trained on healthcare lingo, compliance, and common objections? Domain knowledge — HITRUST, EMR integrations, the difference between selling to a hospital versus a private practice — is what separates a useful partner from a generic one.
• Evaluate their process and communication. A good partner outlines exactly how they’ll integrate: how decision-makers get passed over, how often you’ll review progress, what reporting looks like. Avoid any firm that works in a black box. The best collaborations feel like an extension of your own team.
• Align on messaging and brand. Spend time upfront training the SDRs on your value proposition, product, and tone, and review the initial templates before they go out — they’re contacting prospects under your name, so the first impression must be on-brand and compliant.
• Set clear goals and KPIs. Define success: qualified appointments per month, new hospital contacts, conversion targets. Expect a one-to-two-month ramp as messaging is tuned; by month three you should see solid momentum, and if not, troubleshoot honestly.
• Maintain a feedback loop. Don’t “fire and forget.” Have reps give feedback on lead quality, share product updates and case studies, and listen to front-line insights the SDRs gather (for example, recurring questions about a specific integration). Treat the partner as part of the team.

Done well, a lead generation partner is like adding an experienced prospecting department overnight, and it can propel healthcare growth far faster than going it alone. The key is choosing a partner who understands the unique challenges of healthcare sales and working hand-in-hand toward your revenue goals.

Martal’s Tiered Approach: Outsourced Sales as a Service for Healthcare

At Martal Group, we’ve spent more than a decade helping medtech, health-SaaS, and other B2B companies accelerate healthcare sales through outsourced sales as a service. We operate as a seamless extension of your team: our onshore SDR experts handle cold calling, personalized cold emails, LinkedIn outreach, and follow-ups to engage elusive healthcare decision-makers, while your team focuses on demos and closing. The approach is omnichannel and data-driven from day one — proven cadences (eight-plus touches across phone, email, and social) paired with our Agentic AI platform to reach the right contacts at the right time. Throughout the campaign we share detailed reports and meet with you regularly, so you’re always in the loop.

Clients value the flexible, tiered model. You might start with a fractional SDR engagement — a dedicated team owning one healthcare market end-to-end — then scale into a full team as pipeline grows. No handoffs, no divided attention: the same team that prospects, nurtures, qualifies, and books your meetings stays with you as you grow. We can adjust month to month around a conference, a launch, or a busy close — a partnership on your terms.

Most importantly, we bring a track record in healthcare lead generation, booking meetings with hospital CEOs, clinic directors, IT heads, and other senior stakeholders for clients offering medical devices, EHR software, and telehealth platforms. And unlike agencies that just hand over a list, we work alongside you through the sales cycle — advising on follow-up, sharing field feedback, and iterating to improve results. The goal isn’t just leads; it’s revenue growth and a long-term partnership.

Ready to Fill Your Healthcare Pipeline with Qualified Meetings?

If breaking through to hospital executives, clinical leaders, or healthcare IT directors has been a slow grind, the constraint is rarely the offer — it’s reaching the right people with the right message at the right moment. Martal’s Sales-as-a-Service model pairs experienced onshore SDRs with our Agentic AI platform to run cold email, cold calling, and LinkedIn outreach as one coordinated omnichannel campaign built around your ICP. Trusted by 2,000+ B2B brands across 50+ industries and #1 in Lead Generation on Clutch. Book a consultation and we’ll show you what a qualified healthcare pipeline looks like for your business.